Please assess the completion status of the following clinical trial:

Trial Title: Effects of Lactobacillus Reuteri in Premature Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Preterm newborns admitted to the neonatal intensive care units with a birth weight 700-1500 g and who survive more than 3 days~Exclusion Criteria:~* Chromosomal anomalies.~* Major congenital anomalies (complex cardiac anomalies, congenital hydrocephalus, renal dysplasia)~* Congenital (e.g. jejunal atresia) and acquired (e.g. GI perforation) gastrointestinal pathology precluding oral feed and/or requiring major surgical or medical intervention~* Parental refusal~* Prior enrollment into a conflicting clinical trial

- Gender: ALL
- Minimum Age: None
- Maximum Age: 6 Months
- Healthy Volunteers: f

Study Arms:
- probiotic group (Type: EXPERIMENTAL): Lactobacillus reuteri will be given at a dose of 1x108 colony forming units (CFU)/day
- Placebo (Type: PLACEBO_COMPARATOR): The placebo consists of an identical formulation except that the L. reuteri is not present.

Based on this trial design, predict the completion outcome and termination type (if applicable).